Yee_Wo
20 Sep 2018
Takeover rumour in Daily Mail It only took 8.25 years!, finally it looks like JLT has finally been bought. Looking back at my records I didn’t hold the JLT shares I bought in 2010 @ £5.55 for very long. The holding was sold to invest in BP post Deepwater Horizon. Anyway my 2nd tranche of JLT was bought on 4 Mar 16 @ £8.424, with a little bit of tinkering this year and having sold half my holding (@ £18.68) on hearing the news of the sale of the business I’ve benefitted from an XIRR of 35.5% which ain’t shabby. It should be Champagne Corks, but I’m really somber about a City of London based business potentially losing so many jobs. I must be getting sentimental. Any suggestions on a replacement stock in the Insurance sector to replace my holding in JLT?
Yee Wo
18 May 2018
Project Sherlock - pg 36 Thistle Mag Q1 2018. Project Sherlock, an intelligent semantic, machine learning and AI driven platform conceived by Jardine Lloyd Thompson (JLT) Asia, is currently undergoing Proof of Concept (POC) trials as a winner of the Innovate Jardines ‘Future of Work’ Challenge.The platform is designed to trawl public domain sources and internal systems, collecting relevant data that will generate meaningful new business leads for insurance brokers. This will release brokers from time-consuming research and allow them to focus more on clients.“The primary focus of innovation at JLT is to constantly improve our understanding of our clients’ needs and enable our business teams to offer them a clearly differentiated level of service,” explained JLT Managing Director of Innovation and Product Development Bala Krishnan. “Project Sherlock is the tool of the future that will make this happen.”Medical malpractice insurance for private doctors in Malaysia was selected as the market for POC phase testing. There are approximately 60,000 registered doctors in Malaysia, of whom roughly 15,000 are private practitioners. With the aim of quickly increasing JLT’s market share, Sherlock helps find doctors online, profiles them based on various key factors, and converts specific doctors through online marketing and targeted sales campaigns. To date Project Sherlock has identified over 2,000 doctors in Malaysia, who are not currently clients of JLT, as having the highest likelihood of conversion.A strong team spirit and an agile working attitude have been vital elements of the project, especially given that team members are spread across several countries. The Financial Lines (Healthcare) team in Malaysia, the Hong Kong-based project management team, and the developers and external vendors based in Singapore and India communicate continuously, as well as collaborating closely with Innovate Jardines.JLT Malaysia CEO Dedi Syaripuddin says that Sherlock is about continuous improvement and questioning processes, as much as it is about achieving a specific end state.“Project Sherlock has made us think more deeply about our sales practices, and how we can better utilize data when serving our clients,” he added.JLT is currently finalizing the first POC where the aim is to understand the extent to which conversion rates improve when guided by Sherlock.“Initial results are looking positive,” said Mr Krishnan, “and the next phase of the project is already underway with the aim to make Sherlock a sophisticated B2B or a B2B2C cross-selling and lead prospecting tool.”Commenting on the achievements to date, JLT Asia CEO Dominic Samengo-Turner said, “Creating a structured sales process, guided by sophisticated data analytics, is an integral part of JLT’s strategy to become the world’s leading specialist risk and insurance adviser. Project Sherlock is another step towards that exciting digital future.” Creating a structured sales process, guided by sophisticated data analytics, is an integral part of JLT’s strategy to become the world’s leading specialist risk and insurance adviser. Project Sherlock is another step towards that exciting digital future."
Yee Wo
26 Apr 2016
AGM today FWIW i attended the above. It was over in 25 minutes. I've only very recently re-purchased JLT stock so didn't have any questions. The Gentlemen who did asks questions raised the issue of "losses" in the USA which are being sustained while building out the business there.I managed to get myself a copy of the Annual Report at the AGM. A quick flick through the 2015 numbers did give me plenty to do some research on: - - Why is James Twining leaving and where is he going?- UK&i Employee Benefits business seems a bit strategically lost. Perhaps this explains why HSBC sold it?!- The fees paid to Jardine Matheson Group have gone up from £4.8m to £5.2m. I presume this is nothing more than rent increases in Hongkong and Singapore. If it's not, and scant detail is included in the Annual Report, it's a bit of a piss-take given that Executive Salaries are frozen and the business has made less money than last year, albeit I forgive and understand the exceptionals'.- The Auditors Fees paid to PWC seem a bit strange insofar as they include moving a London based team of auditors around the JLT network (lots of very expensive Flights and Hotels no doubt!). All nice and exotic for the Auditors themselves but the Shareholders are paying for this largesse.- iNEDS not having a shareholding was raised and quite well and IMHO correctly brushed-off by the Chairman.- A damned impressive Office Location.I have a feeling I'll be holding JLT for the VERY long term. The ROCE is good and the scope for an EM recovery remains........
II Editor
06 Nov 2015
NEW ARTICLE: Insider: Bosses go fishing for bargains "Jardine Lloyd Thompson chiefs buy lowLSE:JLT:Jardine Lloyd Thompson is down on its luck. After failing again to make headway much past 1,080p, JLT shares plunged 12% following this week’s third-quarter results, forming a classic double ..."[link]
albent
08 Apr 2015
JLT valuation Further fundamentals on JLT [link]
